I kliniske forsøg forekom disse bivirkninger hyppigere under behandlingen med placebo sammenlignet med Remeron, men ikke statistisk signifikant hyppigere.
In clinical trials these events occurred statistically significantly more frequently during treatment with Remeron than with placebo.